INH preventive therapy (IPT) in HIV-infected south African children

Simple item page
dc.contributor.authorCotton, Mark F.en_ZA
dc.date.accessioned2011-10-13T16:58:56Z
dc.date.available2011-10-13T16:58:56Z
dc.date.issued2011
dc.descriptionCITATION: Cotton, M. F. 2011. INH preventive therapy (IPT) in HIV-infected south African children. Southern African Journal of HIV Medicine, 12(2):a195, doi:10.4102/sajhivmed.v12i2.195.
dc.descriptionThe original publication is available at https://sajhivmed.org.za
dc.description.abstractHIV-infected children have a high risk of acquiring tuberculosis. The World Health Organization (WHO) has released isoniazid preventive therapy (IPT) recommendations for adults and children living with HIV, based on efficacy studies, mainly in adults. Data from children appear conflicting. IPT guidelines for children were developed in response to WHO guidelines at a local meeting, followed by discussions. IPT should be given to all HIV-infected children after exposure to a source case if treatment for active disease is not required. For children whose mothers' HIV status was known antentally, when tuberculosis has been actively excluded in mothers and at infant follow-up, and when infants have commenced antiretroviral therapy in the first 3 months of life, IPT is not required. Otherwise, all infants and children should be given IPT for 6 months once active tuberculosis has been excluded.en_ZA
dc.description.urihttps://sajhivmed.org.za/index.php/hivmed/article/view/195
dc.description.versionPublisher's version
dc.format.extent4 pages
dc.identifier.issn16089693
dc.identifier.urihttp://hdl.handle.net/10019.1/16914
dc.publisherAOSIS
dc.rights.holderAuthor retains copyright
dc.subjectINH preventive therapyen_ZA
dc.titleINH preventive therapy (IPT) in HIV-infected south African childrenen_ZA
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
cotton_inh_2011.pdf
Size:
282.99 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Collection D